These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24331325)

  • 1. The significance of PDGF expression in serum of colorectal carcinoma patients--correlation with Duke's classification. Can PDGF become a potential biomarker?
    Braicu C; Tudoran O; Balacescu L; Catana C; Neagoe E; Berindan-Neagoe I; Ionescu C
    Chirurgia (Bucur); 2013; 108(6):849-54. PubMed ID: 24331325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in serum platelet-derived growth factor (PDGF)-BB reflects lymph node involvement in esophageal cancer patients independently from platelet count.
    Krzystek-Korpacka M; Diakowska D; Gamian A; Matusiewicz M
    Exp Oncol; 2011 Sep; 33(3):140-4. PubMed ID: 21956466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF-BB is a novel prognostic factor in colorectal cancer.
    Nakamura Y; Tanaka F; Yoshikawa Y; Mimori K; Inoue H; Yanaga K; Mori M
    Ann Surg Oncol; 2008 Aug; 15(8):2129-36. PubMed ID: 18478301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum platelet-derived growth factor and fibroblast growth factor in patients with benign and malignant ovarian tumors.
    Madsen CV; Steffensen KD; Olsen DA; Waldstrøm M; Søgaard CH; Brandslund I; Jakobsen A
    Anticancer Res; 2012 Sep; 32(9):3817-25. PubMed ID: 22993324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.
    Qi L; Du J; Zhang Z; Diao L; Chen X; Yao X
    BJU Int; 2013 Aug; 112(4):E415-23. PubMed ID: 23879920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
    Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
    Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer.
    Tian B; Zhang Y; Li N
    Cancer Biother Radiopharm; 2013; 28(6):466-70. PubMed ID: 23745687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma.
    Wu Z; Han X; Yan J; Pan Y; Gong J; Di J; Cheng Z; Jin Z; Wang Z; Zheng Q; Wang Y
    Biomed Pharmacother; 2012 Jul; 66(5):373-7. PubMed ID: 22401929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
    Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
    Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
    Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
    Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
    Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
    Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
    Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
    Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
    Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
    Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
    Bruhn MA; Townsend AR; Khoon Lee C; Shivasami A; Price TJ; Wrin J; Arentz G; Tebbutt NC; Hocking C; Cunningham D; Hardingham JE;
    Int J Cancer; 2014 Aug; 135(3):731-41. PubMed ID: 24374727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
    Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M
    Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.
    Greco C; D'Agnano I; Vitelli G; Vona R; Marino M; Mottolese M; Zuppi C; Capoluongo E; Ameglio F
    Int J Immunopathol Pharmacol; 2006; 19(1):67-79. PubMed ID: 16569345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment.
    Mantur M; Koper O; Snarska J; Sidorska A; Kruszewska-Wnorowska K
    Pol Arch Med Wewn; 2008 Jun; 118(6):345-50. PubMed ID: 18619189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
    McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
    J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.